Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.050 |
None |
1.000 |
5 |
|
2015 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.050 |
None |
1.000 |
5 |
|
2015 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2018 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2016 |
Liver Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
1182
|
189
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.320 |
None |
1.000 |
3 |
|
2017 |
2019 |
Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
919
|
110
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.420 |
None |
1.000 |
2 |
|
2016 |
2019 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.020 |
None |
0.500 |
2 |
|
2006 |
2017 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Autistic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1112
|
395
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2019 |
Pervasive Development Disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
328
|
49
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Isolated systolic hypertension
|
disease |
|
Disease or Syndrome
|
22
|
3
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Compensated cirrhosis
|
disease |
|
Disease or Syndrome
|
23
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
261
|
19
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Uveal melanoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
376
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ataxia, Spinocerebellar
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
156
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
5
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
beta^0^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
34
|
49
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |